Lipid Excipient Targets Multiple Dose Forms

February 5, 2019

A solid lipid excipient from ABITEC is designed for multiple dosing forms.

ABITEC Corporation, a manufacturer of specialty lipids, announced on Feb. 5, 2019 an expansion of its portfolio of excipients for multiple formulations. The new offering, CAPMUL GDB EP/NF, is a monographed glyceryl dibehenate designed for a range of dosing solutions.

The high-purity, highly-reproducible solid lipid excipient offers good flow and uniform particle size distribution for use in multiple formulations including tablets, hard gels, softgels, solid lipid nanoparticles, nano-structured lipids, granulations, multi-particulates, extrudates, congealing, and liquids, the company reports. 

The company also offers specialty lipids for the manufacture of foams, creams, ointments, and lotions produced under cGMP manufacturing.

Source: Abitec